Quantcast
Connect with us

Trump promise involved Ukraine — and Rudy Giuliani is also implicated: Washington Post

Published

on

More information about the whistleblower scandal was revealed Thursday evening in a new bombshell report in The Washington Post.

“A whistleblower complaint about President Trump made by an intelligence official centers on Ukraine, according to two people familiar with the matter, which has set off a struggle between Congress and the executive branch,” the newspaper reported. “The complaint involved communications with a foreign leader and a “promise” that Trump made, which was so alarming that a U.S. intelligence official who had worked at the White House went to the inspector general of the intelligence community, two former U.S. officials said.”

ADVERTISEMENT

Trump spoke by phone with Ukrainian President Volodymyr Zelensky two and a half weeks before the complaint was filed.

“That call is already under investigation by House Democrats who are examining whether Trump and his attorney Rudolph W. Giuliani sought to manipulate the Ukrainian government into helping Trump’s reelection campaign,” The Post noted. “The Democrats’ investigation was launched earlier this month, before revelations that a U.S. intelligence official, who previously worked in the White House, had lodged a complaint with the inspector general for the intelligence community. The Washington Post first reported on Wednesday that the complaint had to do with a “promise” that Trump made when communicating with a foreign leader.”

In September, the chairs of the House Foreign Affairs, Intelligence and Oversight Committees requested more information on Giuliani’s interactions with Ukraine.


Report typos and corrections to: [email protected].
READ COMMENTS - JOIN THE DISCUSSION
Continue Reading

Breaking Banner

Peter Navarro warned Trump coronavirus could kill 500,000 Americans — back in January: NYT

Published

on

President Donald Trump was warned COVID-19 could be catastrophic, according to a bombshell new report published online by The New York Times on Monday evening.

"A top White House adviser starkly warned Trump administration officials in late January that the coronavirus crisis could cost the United States trillions of dollars and put millions of Americans at risk of illness or death," the newspaper reported.

"The warning, written in a memo by Peter Navarro, President Trump’s trade adviser, is the highest-level alert known to have circulated inside the West Wing as the administration was taking its first substantive steps to confront a crisis that had already consumed China’s leaders and would go on to upend life in Europe and the United States," The Times continued.

Continue Reading

Breaking Banner

Oil prices jump on hopes for output cut deal

Published

on

Oil prices rebounded Tuesday on fresh hopes an OPEC-led meeting this week will reach an agreement to reduce oversupply and shore up the market.

Prices have fallen sharply since expectations for a quick deal to cut output levels were dashed, but the rescheduling to Thursday of a meeting of major crude producers boosted sentiment.

US benchmark West Texas Intermediate was up 3.83 percent to $27.08 a barrel in Asian morning trade.

A barrel of Brent crude, the international benchmark, was trading 2.81 percent higher at $33.98.

Prices fell to 18-year lows last week as the market wallowed in oversupply arising from a price war between Saudi Arabia and Russia, which have ramped up production.

Continue Reading
 

Breaking Banner

Trump and his allies have financial ties to companies that manufacture untested drug he’s touting for COVID-19: report

Published

on

President Donald Trump's fixation with hydroxychloroquine, a drug used to treat malaria and lupus, as a potential treatment for the novel coronavirus has left many medical experts, including members of his own administration, frustrated. The drug comes with severe side effects ranging from nausea and hair loss to blindness and cardiac arrest; the hoarding of the drug to test it in COVID-19 patients has resulted in autoimmune patients being denied it, and the evidence that it even helps COVID-19 patients in the first place is anecdotal at best.

Continue Reading
 
 
You need honest news coverage. Help us deliver it. Join Raw Story Investigates for $1. Go ad-free.
close-image